This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Teva Pharmaceuticals’ launch of an authorized generic of liraglutide injection 1.8 mg (Victoza) for type 2 diabetes makes it the first-ever generic GLP-1.
June 24, 2024 — Well-known Chicago and worldwide philanthropist Ann Lurie, namesake of the Ann and Robert H Lurie Children’s Hospital of Chicago, passed away on June 24 after succumbing to glioblastoma, an aggressive form of brain cancer. She was 79. Lurie’s philanthropic efforts were numerous and impactful, and provided vital support to the critical needs of multiple agencies around the world, including initiatives addressing hunger, healthcare deficiencies, animal welfare, arts enrichment and
This analysis among Japanese patients highlights the potential of apremilast for psoriasis patients not responding to topical therapy who may have limited systemic treatment options.
Aakriti Gupta, MD. Photo by Cedars-Sinai milla1cf Mon, 06/24/2024 - 20:17 June 24, 2024 — Aakriti Gupta, MD , and Michelle Kittleson, MD, PhD , cardiologists in the Smidt Heart Institute at Cedars-Sinai , have been selected to join the senior editorial team of the Journal of the American College of Cardiology (JACC), effective July 1. Gupta, an interventional and structural cardiologist, is one of the journal’s new executive associate editors.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
(MedPage Today) -- Note that some links may require registration or subscription. Princess Anne, the 73-year-old sister of King Charles III, sustained minor injuries and a concussion while on a walk; the cause is unclear, but her medical team.
What is the efficacy and safety of a single dose of 120 mg of flecainide acetate oral inhalation solution (FlecIH) administered in a monitored outpatient setting for the conversion of recent-onset atrial fibrillation (AF) to sinus rhythm (SR)?
What is the efficacy and safety of a single dose of 120 mg of flecainide acetate oral inhalation solution (FlecIH) administered in a monitored outpatient setting for the conversion of recent-onset atrial fibrillation (AF) to sinus rhythm (SR)?
(MedPage Today) -- Metabolic surgery became the first therapy associated with a reduction in incident cardiovascular disease and death among patients with obesity and obstructive sleep apnea (OSA), based on a retrospective cohort study. Such patients.
Ralph DeFronzo, MD, discusses the results of the first phase of the CATALYST trial and how results should influence the care of patients with difficult-to-treat type 2 diabetes.
The announcement follows the release of the RhodoLED XL red light-emitting lamp, to be used in combination with aminolevulinic acid hydrochloride topical gel, 10% for actinic keratoses
The first issue of JACC under new Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC, published today, ushering in a new era of one of the world's leading scholarly journals.
Semaglutide reduces body weight to a greater extent in women with obesity-related heart failure with preserved ejection fraction (HFpEF) than in men, and improved Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS) to the same extent in both women and men, according to results from a prespecified secondary analysis of pooled data from the STEP-HFpEF program presented at the American Diabetes Association’s 2024 Scientific Sessions and simultaneously published in JACC.
Anastasia Albanese-O'Neill, PhD, APRN, joins Diabetes Dialogue to discuss newly released consensus guidance on monitoring of early-stage type 1 diabetes spearheaded by Breakthrough T1D.
The goal of the SURMOUNT-OSA trial was to determine the effect of tirzepatide, both alone and in the setting of positive airway pressure (PAP) therapy, on obstructive sleep apnea (OSA) burden in patients with obesity.
Research illustrates that American Heart Association and American Stroke Association guidelines are effective at speeding up hospitals' response times for stroke treatment and can be mastered even by members of 'ad hoc' medical teams that assemble rapidly on the fly.
Findings highlight the potential utility of low-dose SGLT2 inhibitors for optimizing diabetes control and managing renal complications in pediatric patients with type 1 diabetes.
Greater adverse events were associated with both low and high postprocedural aortic valve mean gradient extremes following transcatheter aortic valve implantation (TAVI) for degenerated surgical aortic valve replacement (SAVR) bioprostheses, indicating a complex and nonlinear relationship between gradients and clinical outcomes, according to a recent study published in Circulation: Cardiovascular Interventions.
Dyslipidaemia is a complex disorder characterised by abnormal lipid levels in the blood, including cholesterol and triglycerides, and plays an important role in the development of atherosclerotic cardiovascular disease. Most risk factors for cardiovascular disease are modifiable, and dyslipidaemia is a key factor among them. It can result from a combination of genetic and environmental factors.
Treatment with romosozumab or denosumab demonstrated comparable results among patients with either primary osteoporosis or those with rheumatoid arthritis complicated with osteoporosis over a 24-month period.
RCES-Scope-of-Practice-ACVP-2017 Available for download! The Electrophysiology Laboratory (EPL) is one of the most unique medical environments in existence today. The goal of the electrophysiology lab is to perform diagnostic studies to obtain sufficient electrocardiographic and radiologic data regarding bradyarrhythmias, or tachyarrythmias, and then to perform interventional procedures while maintaining maximal patient safety and comfort.
As a leader in the field of research-based cardiometabolic health education, CMHC is proud to present its CME education outcomes study at ADA (American Diabetes Association) 2024 Scientific Sessions, which offers its education-focused agenda to a wide number of healthcare practitioners from all areas of the U.S. Boca Raton, FL, June 24, 2024 (GLOBE NEWSWIRE) — The ADA 2024 Scientific Sessions center on the latest cutting-edge advances in diabetes research, prevention, and care.
Publication date: Available online 24 June 2024 Source: The American Journal of Cardiology Author(s): Carlo Mannina, Lakshay Chopra, Joseph Maenza, Francesca R Prandi, Edgar Argulian, Michael Hadley, Jonathan Halperin, Samin K Sharma, Annapoorna Kini, Stamatios Lerakis
The CATALYST trial sheds light on the true prevalence of hypercortisolism among difficult-to-control type 2 diabetes, with data at ADA 2024 shedding light on adrenal abnormalities and presence among subgroups.
Cardiovascular magnetic resonance (CMR) has developed over the past 50 years as an advantageous noninvasive imaging modality. Recently published in Circulation , Gregory Hundley reviews CMR’s evolution and its current pivotal role in cardiovascular care. Three Developmental Stages The development of CMR can be divided into three stages: the origins of clinical use of magnetic resonance in imaging, the development of CMR-specific methods and techniques, and the integration of CMR into cardiovascu
Study results highlight the impact of continuous glucose monitoring on glucose control and HbA1c improvements in patients with type 2 diabetes, regardless of treatment regimen.
BackgroundCannabis is one of the most widely used psychoactive substances. Its components act through several pathways, producing a myriad of side effects, of which cardiovascular events are the most life-threatening. However, only a limited number of studies address cannabis's perioperative impact on patients during noncardiac surgery.MethodsStudies were identified by searching the PubMed, Medline, EMBASE, and Google Scholar databases using relevant keyword combinations pertinent to the topic.R
Patients who achieved early remission with upadacitinib or adalimumab following an inadequate response to methotrexate had less pain/fatigue and better physical quality of life.
Artificial intelligence (AI) has tremendous potential to transform cardiovascular care in several key areas, from discovery to practice, according to a JACC State-of-the-Art Review published June 24.
Vagal atrial fibrillation (AF) occurs in relatively young people without any organic heart disease, and its onset is caused by changes in autonomic nervous system tone, mainly parasympathetic, such as after eating or drinking alcohol. Clinical results demonstrate that pulmonary vein isolation (PVI) remains the cornerstone of AF ablation in these patients, but additional ablation of the ganglionated plexi (GP) has been proposed as a complementary strategy.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content